Early-life Pb exposure as a potential risk factor for Alzheimer's disease: are there hazards for the Mexican population?

被引:9
|
作者
Chin-Chan, Miguel [1 ,4 ]
Cobos-Puc, Luis [2 ]
Alvarado-Cruz, Isabel [3 ]
Bayar, Melike [4 ]
Ermolaeva, Maria [4 ]
机构
[1] Autonomous Univ Campeche, Fac Chem & Biol Sci, Campeche, Campeche, Mexico
[2] Autonomous Univ Coahuila, Fac Chem Sci, Saltillo, Coahuila, Mexico
[3] Yale Univ, Sch Med, Therapeut Radiol Dept, New Haven, CT 06520 USA
[4] Leibniz Inst Aging Fritz Lipmann Inst, Jena, Germany
来源
JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY | 2019年 / 24卷 / 08期
关键词
Alzheimer's disease; Epigenetics; Heavy metals; Lead; Pollution; Mexico; AMYLOID PRECURSOR PROTEIN; BLOOD LEAD LEVELS; DNA METHYLATION; INFANTILE EXPOSURE; OXIDATIVE STRESS; CEREBRAL-CORTEX; A-BETA; ENVIRONMENTAL LEAD; COGNITIVE DECLINE; TAU PATHOLOGY;
D O I
10.1007/s00775-019-01739-1
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Alzheimer's disease (AD) is the main cause of dementia in elderly. Increasing life expectancy is behind the growing prevalence of AD worldwide with approximately 45 million cases currently documented and projection studies suggesting a triplication of this number by 2050. Mexico does not have an accurate AD registry, but 860,000 cases were reported in 2014 and the prediction reaches 3.5 million cases by 2050. Amyloid plaques and neurofibrillary tangles represent the main hallmarks of AD, being constituted of amyloid beta (A beta) peptide and phosphorylated tau, respectively. The risk factors for AD include genetic mutations, lifestyle and environmental pollution. Particularly, lead (Pb) has attracted attention due to its ability to target multiple pathways involved in the pathophysiology of AD. Although the epidemiological data are limiting, animal and in vitro studies show growing evidence of causal effects of Pb exposure on AD-linked features including A beta aggregation and tau phosphorylation. Interestingly, many Pb effects occur selectively following early-life exposure to the metal, suggesting an epigenetic mechanism. This hypothesis is supported by changes in DNA methylation and microRNA expression patterns inflicted by early-life Pb exposure. Pb pollution in Mexico represents a significant problem because past and current mining activities, historical use of Pb as fuel additive and culturally rooted use of Pb in glazed ceramics, contribute to high levels of Pb pollution in Mexico. In this review we will discuss potential risks of AD development in Mexican populations chronically exposed to Pb in their childhood.
引用
收藏
页码:1285 / 1303
页数:19
相关论文
共 50 条
  • [21] Early life socioeconomic status and late life risk of Alzheimer's disease
    Wilson, RS
    Scherr, PA
    Hoganson, G
    Bienias, JL
    Evans, DA
    Bennett, DA
    NEUROEPIDEMIOLOGY, 2005, 25 (01) : 8 - 14
  • [22] Early-life events may trigger biochemical pathways for Alzheimer’s disease: the “LEARn” model
    Debomoy K. Lahiri
    Nasser H. Zawia
    Nigel H. Greig
    Kumar Sambamurti
    Bryan Maloney
    Biogerontology, 2008, 9
  • [23] The "LEARn" (Latent Early-life Associated Regulation) model integrates environmental risk factors and the developmental basis of Alzheimer's disease, and proposes remedial steps
    Lahiri, Debomoy K.
    Maloney, Bryan
    EXPERIMENTAL GERONTOLOGY, 2010, 45 (04) : 291 - 296
  • [24] Early-life events may trigger biochemical pathways for Alzheimer's disease: the "LEARn" model
    Lahiri, Debomoy K.
    Zawia, Nasser H.
    Greig, Nigel H.
    Sambamurti, Kumar
    Maloney, Bryan
    BIOGERONTOLOGY, 2008, 9 (06) : 375 - 379
  • [25] Sarcopenia as a Risk Factor for Alzheimer's Disease: Genetic and Epigenetic Perspectives
    Raleigh, Stuart M.
    Orchard, Kayleigh J. A.
    GENES, 2024, 15 (05)
  • [26] APOE4 is a Risk Factor and Potential Therapeutic Target for Alzheimer's Disease
    Ayyubova, Gunel
    CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2024, 23 (03) : 342 - 352
  • [27] Mechanisms Underlying Latent Disease Risk Associated with Early-Life Arsenic Exposure: Current Research Trends and Scientific Gaps
    Bailey, Kathryn A.
    Smith, Allan H.
    Tokar, Erik J.
    Graziano, Joseph H.
    Kim, Kyoung-Woong
    Navasumrit, Panida
    Ruchirawat, Mathuros
    Thiantanawat, Apinya
    Suk, William A.
    Fry, Rebecca C.
    ENVIRONMENTAL HEALTH PERSPECTIVES, 2016, 124 (02) : 170 - 175
  • [28] Metabolic Syndrome as a Risk Factor for Alzheimer's Disease: Is Aβ a Crucial Factor in Both Pathologies?
    Campos-Pena, Victoria
    Toral-Rios, Danira
    Becerril-Perez, Fernando
    Sanchez-Torres, Carmen
    Delgado-Namorado, Yair
    Torres-Ossorio, Elimar
    Franco-Bocanegra, Diana
    Carvajal, Karla
    ANTIOXIDANTS & REDOX SIGNALING, 2017, 26 (10) : 542 - +
  • [29] Depression as a Risk Factor for Dementia and Alzheimer's Disease
    Canton-Habas, Vanesa
    Rich-Ruiz, Manuel
    Romero-Saldana, Manuel
    Carrera-Gonzalez, Maria del Pilar
    BIOMEDICINES, 2020, 8 (11) : 1 - 15
  • [30] Apolipoprotein E3 as a Risk Factor for Alzheimer's Disease Under Conditions of Nutritional Imbalance
    Chan, Amy
    Shea, Thomas B.
    JOURNAL OF ALZHEIMERS DISEASE, 2010, 21 (01) : 49 - 55